F1000Research, the first Open Science publisher, has announced that articles published in its innovative publishing system will be listed in PubMed, which claims to be the largest and most-used biomedical literature database.
F1000Research is F1000’s new open access publishing program that offers immediate publication followed by a thorough and completely open peer review process, executed after publication. Following recent approval by the National Library of Medicine (NLM)'s Selections group, all articles that pass this peer review process will now be listed in PubMed and deposited within PubMed Central.
F1000Research’s acceptance by the NLM Selections group follows agreements confirmed with Elsevier in 2012 for the indexing of F1000Research articles in Scopus and Embase.
F1000Research accepts all scientifically sound articles. In addition to traditional articles, F1000Research accepts articles ranging from single findings, datasets, short articles, case reports, protocols, replications, and null or negative results to opinion pieces and reviews.
More News in this Theme
